Accelovance Continues Growth with Key US Sales Hires

Bruce Wakeman

We have built an impressive sales team with advanced abilities to understand, anticipate and satisfy our clients’ needs.

Accelovance, Inc., a global contract research organization (CRO) specializing in oncology, vaccines/immunology and general medicine, recently hired Christine Lys and Katie Winter as Associate Vice Presidents, Business Development.

Christine Lys is located in San Diego, CA and is responsible for clients in the Western US region. She has been in the clinical research industry for more than 20 years, most recently with a specialized medical device CRO combining strategic consultation and services. Christine brings to Accelovance a strong background in clinical research methodology across therapeutic areas and treatment types including pharmaceutical, biologic and medical device. She is an advocate for optimal research efficiencies, having represented software companies’ solutions to collect and analyze patient and clinical data. Christine holds a BS in Psychology, a Master’s in Biology from Case Western Reserve University and has authored/co-authored many clinical manuscripts and abstracts.

Katie Winter is located in the Boston, MA area and is responsible for clients in the Northeast US region. She brings an equally impressive background, with over 16 years of consultative CRO sales experience, significant drug development knowledge and degrees in both Business Management and Nursing. Katie’s career focus has been on clinical trial management in all phases of drug development: Phase I through Phase III, proof of concept studies, dose-escalation, post-marketing approval, risk evaluation and mitigation strategies (REMS) and disease registries. She also has hands-on…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *